Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
University of Virginia
Fate Therapeutics
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Tocagen Inc.
Vanderbilt-Ingram Cancer Center
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University of Arizona
Rutgers, The State University of New Jersey
Mirna Therapeutics, Inc.
Vanderbilt University
Titan Pharmaceuticals